ALX Oncology (ALXO) Insider Trading & Ownership $1.30 -0.16 (-10.62%) Closing price 04:00 PM EasternExtended Trading$1.32 +0.02 (+1.15%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALX Oncology (NASDAQ:ALXO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$198,624.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.83 M Get ALXO Insider Trade Alerts Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALXO Insider Buying and Selling by Quarter ALX Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2025Shelly PintoCFOSell2,221$1.80$3,997.80 12/30/2024Jaume PonsInsiderSell10,796$1.58$17,057.68 12/30/2024Shelly PintoCFOSell1,426$1.58$2,253.08 12/2/2024Rekha HemrajaniDirectorBuy30,000$1.55$46,500.00 8/14/2024Shelly PintoCAOSell564$2.58$1,455.12 8/14/2024Sophia RandolphInsiderSell1,365$2.58$3,521.70 7/11/2024Jaume PonsInsiderSell20,000$7.90$158,000.00 7/5/2024Shelly PintoCAOSell1,823$5.50$10,026.50 7/1/2024Shelly PintoCAOSell1,373$5.82$7,990.86 7/1/2024Sophia RandolphInsiderSell3,273$5.82$19,048.86 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/13/2024Peter S GarciaCFOBuy12,000$8.53$102,360.00 6/4/2024Jaume PonsInsiderSell20,000$8.43$168,600.00 5/13/2024Sophia RandolphInsiderSell12,000$15.94$191,280.00 5/6/2024Jaume PonsInsiderSell20,000$15.92$318,400.00 4/16/2024Jaume PonsInsiderSell50,000$14.20$710,000.00 4/4/2024Jaume PonsInsiderSell20,000$11.15$223,000.00 3/14/2024Jason LettmannCEOBuy4,400$11.31$49,764.00 (Data available from 1/1/2013 forward) ALXO Insider Trading Activity - Frequently Asked Questions Who is on ALX Oncology's Insider Roster? The list of insiders at ALX Oncology includes Jason Lettmann, Jaume Pons, Peter S Garcia, Rekha Hemrajani, Shelly Pinto, and Sophia Randolph. Learn more on insiders at ALXO. What percentage of ALX Oncology stock is owned by insiders? 33.40% of ALX Oncology stock is owned by insiders. Learn more on ALXO's insider holdings. Which ALX Oncology insiders have been buying company stock? The following insiders have purchased ALXO shares in the last 24 months: Jason Lettmann ($49,764.00), Peter S Garcia ($102,360.00), and Rekha Hemrajani ($46,500.00). How much insider buying is happening at ALX Oncology? Insiders have purchased a total of 46,400 ALXO shares in the last 24 months for a total of $198,624.00 bought. Which ALX Oncology insiders have been selling company stock? The following insiders have sold ALXO shares in the last 24 months: Jaume Pons ($1,618,604.40), Peter S Garcia ($6,510.58), Shelly Pinto ($113,984.40), and Sophia Randolph ($225,631.26). How much insider selling is happening at ALX Oncology? Insiders have sold a total of 181,069 ALX Oncology shares in the last 24 months for a total of $1,964,730.64 sold. ALX Oncology Key ExecutivesDr. Corey S. Goodman Ph.D. (Age 72)Executive Chairman Compensation: $84kMr. Jason W. Lettmann (Age 47)CEO & Director Compensation: $60.5kDr. Jaume Pons Ph.D. (Age 57)Founder, President, Director & Chief Scientific Officer Compensation: $856.29kMr. Peter S. Garcia M.B.A. (Age 62)Chief Financial Officer Compensation: $631.11kDr. Sophia Randolph M.D. (Age 56)Ph.D., Chief Medical Officer & Director Compensation: $637.24kDr. Michael Chang Ph.D.Vice President of OperationsMs. Shelly Pinto (Age 47)Senior VP of Finance & Chief Accounting Officer Compensation: $508.26k3 recent tradesDr. Christopher Byrd J.D.Ph.D., General CounselDr. Athanasios Tsiatis M.D.Senior Vice President of Clinical DevelopmentDr. Lin Yeong-Liang M.D.M.S., Senior Vice President of Drug Safety & Pharmacovigilance More Insider Trading Tools from MarketBeat Related Companies Corvus Pharmaceuticals Insider Buying Neumora Therapeutics Insider Buying biote Insider Buying Taysha Gene Therapies Insider Buying Voyager Therapeutics Insider Buying Trevi Therapeutics Insider Buying enGene Insider Buying Atyr PHARMA Insider Buying Design Therapeutics Insider Buying Y-mAbs Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:ALXO) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
